Spots Global Cancer Trial Database for polymorphism analysis
Every month we try and update this database with for polymorphism analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia | NCT00896766 | Leukemia | loss of heteroz... microarray anal... polymorphism an... tumor replicati... | 1 Year - 21 Years | Children's Oncology Group | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer | NCT00460200 | Depression Fatigue Ovarian Cancer Psychosocial Ef... Sleep Disorders | polymorphism an... laboratory biom... physiologic tes... questionnaire a... conventional su... fatigue assessm... psychosocial as... | 18 Years - 55 Years | Jonsson Comprehensive Cancer Center | |
| Irinotecan in Treating Patients With Colorectal Cancer | NCT00003843 | Colorectal Canc... | irinotecan hydr... mutation analys... polymorphism an... | 18 Years - | California Cancer Consortium | |
| Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 | NCT00914043 | Breast Cancer Fatigue | gene expression... microarray anal... polymerase chai... polymorphism an... reverse transcr... biologic sample... enzyme-linked i... laboratory biom... fatigue assessm... | - | NSABP Foundation Inc | |
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin | NCT01120262 | Prostate Cancer | gene expression... polymorphism an... laboratory biom... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom | NCT00757211 | Breast Cancer | polymorphism an... laboratory biom... questionnaire a... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524 | NCT00898820 | Lung Cancer | gene expression... polymorphism an... protein express... | 18 Years - | Mayo Clinic | |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone | NCT00933127 | Lymphoma | DNA analysis polymerase chai... polymorphism an... laboratory biom... | 18 Years - | SWOG Cancer Research Network | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 | NCT00967239 | Breast Cancer | DNA analysis polymorphism an... laboratory biom... pharmacogenomic... | 35 Years - | NSABP Foundation Inc | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients | NCT04581967 | Breast Cancer P... | polymorphism an... Doxorubicin-Cyc... | 18 Years - 75 Years | Damanhour University | |
| Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer | NCT00766454 | Breast Cancer | DNA analysis mutation analys... polymorphism an... laboratory biom... medical chart r... questionnaire a... evaluation of c... | - 120 Years | Wake Forest University Health Sciences | |
| DNA Variations in the Gene in Young Patients With Wilms' Tumor | NCT00088803 | Kidney Cancer | molecular genet... polymerase chai... polymorphism an... | - 18 Years | Children's Oncology Group | |
| Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer | NCT01327794 | Pancreatic Canc... | polymorphism an... immunologic tec... laboratory biom... medical chart r... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma | NCT00670358 | Lymphoma | pegfilgrastim rituximab cyclophosphamid... doxorubicin hyd... lenalidomide prednisone vincristine sul... polymorphism an... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma | NCT01045928 | Adult Non-Hodgk... Adult Grade III... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Cutaneous B-cel... Extranodal Marg... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Stage I Adult B... Stage I Adult D... Stage I Adult D... Stage I Adult D... Stage I Adult I... Stage I Adult L... Stage I Grade 1... Stage I Grade 2... Stage I Grade 3... Stage I Mantle ... Stage I Margina... Stage I Small L... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Waldenstrom Mac... | lenalidomide rituximab polymerase chai... nucleic acid se... polymorphism an... flow cytometry laboratory biom... | 18 Years - | Case Comprehensive Cancer Center | |
| Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | NCT01126450 | Colon Cancer Rectal Cancer | lenalidomide cetuximab mutation analys... polymerase chai... polymorphism an... | 18 Years - | Case Comprehensive Cancer Center | |
| Study of a Polymorphism in Patients With Prostate Cancer | NCT00900185 | Prostate Cancer | mutation analys... polymerase chai... polymorphism an... | - | National Cancer Institute (NCI) | |
| Genetics of Women With Lobular Carcinoma in Situ of the Breast | NCT00536718 | Breast Cancer | gene expression... molecular diagn... polymorphism an... protein express... medical chart r... questionnaire a... | - 60 Years | National Cancer Institute (NCI) | |
| Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | NCT00538291 | Colorectal Canc... | cetuximab capecitabine gene expression... microarray anal... polymorphism an... reverse transcr... immunohistochem... | 18 Years - | City of Hope Medical Center | |
| Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT00467142 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... polymorphism an... | 18 Years - 120 Years | Institut Bergonié | |
| Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 | NCT00897351 | Prostate Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | NCT01206465 | Unspecified Adu... | pralatrexate fluorouracil laboratory biom... DNA analysis high performanc... polymerase chai... nucleic acid se... pharmacological... pharmacogenomic... polymorphism an... | 19 Years - | University of Nebraska | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | NCT00486356 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Liver Cancer Unspecified Adu... | capecitabine carboplatin epirubicin hydr... microarray anal... polymorphism an... pharmacological... | 18 Years - 120 Years | University of Nebraska | |
| Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia | NCT01269385 | B-cell Chronic ... Refractory Chro... Stage 0 Chronic... Stage I Chronic... Stage II Chroni... | alemtuzumab rituximab PGG beta-glucan flow cytometry laboratory biom... DNA analysis fluorescence in... polymerase chai... polymorphism an... mutation analys... | 18 Years - | Mayo Clinic | |
| Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer | NCT01013129 | Hereditary Pros... Prostate Cancer | DNA analysis polymorphism an... laboratory biom... medical chart r... questionnaire a... evaluation of c... study of high r... | 21 Years - 120 Years | Portland VA Medical Center | |
| S0916, MLN1202 in Treating Patients With Bone Metastases | NCT01015560 | Metastatic Canc... Unspecified Adu... | anti-CCR2 monoc... polymorphism an... laboratory biom... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Studying Genes in Samples From Younger Patients With Adrenocortical Tumor | NCT01528956 | Adrenocortical ... | DNA methylation... RNA analysis gene expression... nucleic acid se... polymorphism an... | - 21 Years | Children's Oncology Group | |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01653613 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom... | 16 Years - 39 Years | National Cancer Institute (NCI) | |
| Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia | NCT00898456 | Leukemia | gene expression... molecular genet... polymorphism an... protein express... diagnostic labo... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882 | NCT00898469 | Leukemia | polymorphism an... | 10 Years - 120 Months | Children's Oncology Group | |
| Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer | NCT00691509 | Breast Cancer | gene expression... polymorphism an... high performanc... laboratory biom... mass spectromet... questionnaire a... | - 75 Years | National Cancer Institute (NCI) | |
| Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer | NCT01338792 | Hormone-resista... Recurrent Prost... | oxaliplatin pemetrexed diso... questionnaire a... laboratory biom... reverse transcr... polymorphism an... | 18 Years - | University of Southern California | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy | NCT01145469 | Leukemia | DNA analysis gene expression... polymorphism an... laboratory biom... medical chart r... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer | NCT02428101 | Gastrointestina... Peripheral Neur... | polymorphism an... | 18 Years - 80 Years | Ain Shams University | |
| Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer | NCT00467129 | Colorectal Canc... | microarray anal... mutation analys... polymerase chai... polymorphism an... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| Study of DNA Samples From Patients With Multiple Myeloma | NCT00898040 | Multiple Myelom... | polymorphism an... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer | NCT00766454 | Breast Cancer | DNA analysis mutation analys... polymorphism an... laboratory biom... medical chart r... questionnaire a... evaluation of c... | - 120 Years | Wake Forest University Health Sciences | |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | NCT00851552 | Lymphoma | rituximab bortezomib pegylated lipos... gene expression... polymerase chai... polymorphism an... proteomic profi... flow cytometry laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| Biomarkers in Young Patients With Neuroblastoma | NCT01169376 | Neuroblastoma | DNA analysis DNA methylation... RNA analysis comparative gen... mutation analys... polymorphism an... | - 30 Years | Children's Oncology Group | |
| Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel | NCT00900172 | Lung Cancer | bevacizumab carboplatin paclitaxel gene expression... polymerase chai... polymorphism an... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | NCT00611000 | Colorectal Canc... | folic acid DNA methylation... gene expression... microarray anal... polymorphism an... laboratory biom... | 40 Years - 72 Years | National Cancer Institute (NCI) | |
| S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma | NCT00898183 | Melanoma (Skin) | gene expression... polymorphism an... | 18 Years - | SWOG Cancer Research Network | |
| S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma | NCT00985699 | Lymphoma | polymorphism an... laboratory biom... pharmacogenomic... | 18 Years - | SWOG Cancer Research Network | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma | NCT01476410 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Stage II Adult ... Stage III Adult... Stage IV Adult ... | brentuximab ved... doxorubicin hyd... vinblastine dacarbazine quality-of-life... DNA analysis RNA analysis fludeoxyglucose... positron emissi... laboratory biom... immunohistochem... polymorphism an... | 60 Years - | Northwestern University | |
| GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00893477 | Lymphoma | rituximab sargramostim gene expression... gene rearrangem... polymerase chai... polymorphism an... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia | NCT00769327 | Leukemia | imatinib mesyla... nilotinib cytogenetic ana... fluorescence in... microarray anal... mutation analys... polymerase chai... polymorphism an... laboratory biom... | 18 Years - 120 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma | NCT00360854 | Brain and Centr... | erlotinib hydro... mutation analys... polymorphism an... laboratory biom... pharmacological... radiation thera... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma | NCT00670358 | Lymphoma | pegfilgrastim rituximab cyclophosphamid... doxorubicin hyd... lenalidomide prednisone vincristine sul... polymorphism an... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030 | NCT00899535 | Lung Cancer | DNA analysis RNA analysis microarray anal... mutation analys... polymorphism an... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma | NCT00898183 | Melanoma (Skin) | gene expression... polymorphism an... | 18 Years - | SWOG Cancer Research Network | |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01653613 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom... | 16 Years - 39 Years | National Cancer Institute (NCI) | |
| Study of Blood and Cheek Cell Samples From Patients With Glioma | NCT01009307 | Brain and Centr... | polymorphism an... laboratory biom... medical chart r... | 18 Years - 120 Years | University of California, San Francisco | |
| Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck | NCT01192815 | Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... | erlotinib hydro... intensity-modul... pharmacogenomic... gene expression... 3-dimensional c... biopsy pharmacological... laboratory biom... questionnaire a... enzyme-linked i... polymorphism an... | 18 Years - 70 Years | Case Comprehensive Cancer Center | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | NCT00758173 | Prostate Cancer | polymorphism an... laboratory biom... questionnaire a... | 18 Years - 74 Years | National Cancer Institute (NCI) | |
| Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer | NCT02428101 | Gastrointestina... Peripheral Neur... | polymorphism an... | 18 Years - 80 Years | Ain Shams University | |
| Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies | NCT01567722 | Lung Cancer Lymphoma | DNA analysis RNA analysis gene expression... polymorphism an... biologic sample... flow cytometry medical chart r... | 18 Years - | AIDS Malignancy Consortium | |
| Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer | NCT01013129 | Hereditary Pros... Prostate Cancer | DNA analysis polymorphism an... laboratory biom... medical chart r... questionnaire a... evaluation of c... study of high r... | 21 Years - 120 Years | Portland VA Medical Center | |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT01557959 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Non-small Cell ... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cisplatin pegfilgrastim erlotinib hydro... laboratory biom... polymorphism an... pharmacogenomic... genetic linkage... docetaxel | 18 Years - | Wake Forest University Health Sciences | |
| Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom | NCT00757965 | Colorectal Canc... | polymorphism an... laboratory biom... questionnaire a... | 18 Years - 69 Years | National Cancer Institute (NCI) | |
| Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients | NCT04581967 | Breast Cancer P... | polymorphism an... Doxorubicin-Cyc... | 18 Years - 75 Years | Damanhour University | |
| Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | NCT00514020 | Gastric Cancer | fluorouracil leucovorin calc... oxaliplatin gene expression... polymorphism an... protein express... pharmacological... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression | NCT01433224 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer Testicular Germ... | DNA methylation... RNA analysis mutation analys... nucleic acid se... polymerase chai... polymorphism an... laboratory biom... medical chart r... | - | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
